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Isolated rat hepatocyte metabolism is affected by chronic renal failure.
Metabolic changes due to chronic renal failure (CRF) were studied in
isolated liver cells. In 14 CRF and 14 sham-operated rats, liver cells were
isolated by the Beriy and Friend method and incubated with various
substrates in order to study gluconeogenesis, ureagenesis, ketogenesis,
oxygen consumption as well as cytosolic and mitochondrial adenine
nucleotide content. CRF rat hepatocytes exhibited a 25% to 45% decrease
in gluconeogenesis and ureagenesis (P < 0.05) from all the tested
substrates (lactate plus pyruvate, fructose, glycerol, dihydroxyacetone,
alanine and glutamine for gluconeogenesis and alanine, glutamine, am-
monia and ammonia plus ornithine for ureagenesis), while endogenous
rates were unaffected. CRF did not alter ketone body production (aceto-
acetate and 3-hydroxybutyrate) from oleate or octanoate. In the presence
of either oleate, lactate plus pyruvate or ammonia, oxygen uptake as well
as cytosolic and mitochondrial total adenine nucleotides were unaffected
by CRF, while the mitochondrial ATP/ADP ratio decreased (P < 0.001).
Thus, this study of hepatocyte intermediary metabolism during CRF
showed an alteration of only gluconeogenesis and ureagenesis pathways.
Moreover, the association of normal oxygen uptake together with de-
creased mitochondrial ATP/ADP ratio suggest a possible increase in
hepatocyte ATP demand during uremia.
During chronic renal failure (CRF), protein malnutrition is
common and is responsible for increased morbidity and mortality
[1—8]. In this condition, several abnormalities of hepatosplanchnic
nutrient utilization have been described in vivo. In particular:
(1) amino acid exchanges have been shown to be impaired both in
absorptive [9, 10] and in post-absorptive phases [11]; (2) de-
creased ureagenesis has been reported [11, 12]; (3) protein meals
are followed by an enhancement of the blood amino acid distur-
bances observed at basal state [13]; and (4) impairments of
carbohydrate metabolism involving gluconeogenesis and glycogen
storage have been described [14, 15]. Liver dysfunction is mainly
responsible for these metabolic alterations. Such abnormalities of
nutrient utilization and/or release by the liver could be due either
to general uremia-related factors or to hepatocyte dysfunction.
Although numerous studies on urea synthesis have been per-
formed during experimental CRF [16—22], the effect of CRF on
liver metabolism has not been extensively explored at a cellular
level, To our knowledge, only one study on isolated hepatocyte
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has been reported under these conditions [23], and it focused on
ureagenesis and gluconeogenesis from alanine, glutamine and
serine. The present work was undertaken to assess the main
pathways of isolated-hepatocyte intermediary metabolism during
CRF, that is, gluconeogenesis, ureagenesis, ketone body produc-
tion and cell energy status. These investigations, performed on
CRF and sham-operated control rats, showed a decrease in
gluconeogenesis and ureagenesis pathways without change in
ketogenesis. Morever, cellular 02 consumption was either slightly
enhanced or unaffected by CRF while the mitochondrial ATP/
ADP ratio was significantly decreased. These results are in favor
of an increased ATP consumption although a change in ATP
synthesis efficacy cannot be entirely ruled out.
Methods
Animals
In 14 male Wistar rats weighing 300 to 350 g, CRF was obtained
by a 3/4 left renal artery ligation and, after two weeks, a right
nephrectomy (method modified from Avioli et al [241). Rats were
included in the study when they presented, three weeks after the
nephrectomy, with a plasma creatinine higher than 1.5-fold the
mean of control creatinine. The control group was comprised of
14 sham-operated animals which underwent 2 laparotomies with-
out renal procedure at the time of uremic rat operations. Control
and CRF rats were fed with stock pellets given ad libitum. At the
time of metabolic studies, CRF rats presented with elevated
plasma creatinine (112.38 9.54 vs. 52.46 2.23 mol/liter,
mean sn) and urea (19.22 1.45 vs. 6.99 0.32 mmol/liter).
Body mass was similar in the two groups: 341 9 versus 361 4
g. During the week before metabolic studies, daily food intakes
were 22 3 g (mean SD) in controls and 22 4 g in CRF rats.
Isolation and incubation of liver cells
Hepatocytes were isolated from 24-hour starved rats according
to the method of Berry and Friend [25] as modified by Groen et
al. [26]. Incubations were performed in closed vials at 37°C in a
shaking water bath (60 strokes/mm). Incubates were composed of
Krebs-bicarbonate buffer (NaC1 120 mrvt, KCI 4.8 mM, KH2PO4
1.2 mrvi, Mg504 1.2 mivi, NaHCO3 24 mtst, Ca2: 2.4 mrvi, pH 7.4)
and bovine serum albumin-oleate (2% to 2 mM). For the keto-
genesis study, fatty acid free bovine serum albumin was used and
octanoate or oleate were separately added. The gas atmosphere
was 02/C02 (19:1).
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Table 1. Urea and glucose production
Urea Glucose
Cont (15) CRF (15) Cont (8) CRF (8)
Endogenous rate 34 4 36 2 20 4 18 1
Lactate + pyruvate 542 40 329 49
Fructose 770 64 523 74
Dihydroxyacetone 811 43 477 65
Glycerol 186 5 102 15
Alanine 152 9 97 T 202 11 157 iia
Glutamine 387 20 256 20 207 8 137 iia
Ammonia 147 17 85 7
Ammonia+ornithine 242 14 201 12
Isolated hepatocytes from chronic renal failure (CRF) and control
(Cont) rats were incubated for 60 minutes. The number of incubations in
each condition is given in parentheses. Substrate concentrations were 20
m, except for ammonia 5 mi, pyruvate and ornithine 2 m. Results are
expressed as mol/g dry mass, mean SE.
a Significant differences between the 2 groups, P < 0.05.
For giuconeogenesis and/or ureagenesis studies, hepatocytes
(final concentration of approximately 13 mg dry cell/mi) were
incubated with: no addition (endogenous rate), lactate plus pyru-
vate (20-2 mM), fructose, dihydroxyacetone, glycerol, alanine,
glutamine (20 mM), ammonia (5 mM) and ammonia plus ornithine
(5 mM-2 mM). Ureagenesis was studied both with ammonia and
ammonia plus ornithine in order to avoid a rate-limiting effect of
low endogenous ornithine content on citrulline formation and
urea synthesis [27, 281. At the beginning of incubations (to) and
after 60 minutes (t60), 0.5 ml samples of the cell suspension were
taken and quenched into perchloric acid [HC1O4, final concentra-
tion 5% (mass/vol)], then centrifuged at 13,500 g for five minutes.
The supernatant was neutralized with KOH (2 M)-morphohnopro-
pane sulphonic acid (0.3 M) for subsequent glucose and urea
determinations.
For ketogenesis measurements, hepatocytes were incubated for
20 minutes with no addition, oleate (2 mM) and octanoate (2 mM).
Samples of cell suspension (0.7 ml) were taken at tO and t20 and
treated as described above for /3-hydroxybutyrate and acetoace-
tate measurements.
We also investigated 02 consumption and cytosolic and mito-
chondrial adenine nucleotide contents. Hepatocytes were incu-
bated for 20 minutes with no addition, oleate (2 mM), oleate plus
lactate plus pyruvate (2 mM-20 mM-2 mM), oleate plus ammonia
(2 mM-5 mM) and oleate plus lactate plus pyruvate plus ammonia
(2 mM-20 mM-2 mM-S mM). At t20, 0.5 ml of cell suspension were
taken from the incubation vials and put into an oxygraph for 02
uptake measurements. Simultaneously, 0.3 ml of the cell suspen-
sion were treated with digitonin to separate cytosolic and mito-
chondrial spaces. As described by Zuurendonk et al [29, 30] and
with previously reported modifications [31], the digitonin-treated
cell suspension was centrifuged through a layer of silicone oil for
subsequent measurements of adenylic nucleotides.
Metabolite assays
Metabolites were measured in neutralized protein-free extracts.
Glucose [32], urea [33], /3-hydroxybutyrate [34] and acetoacetate
[35] were determined spectrophotometrically. Adenylic nucleoti-
des were separated by high-performance liquid chromatography
as previously described [31].
Table 2. Ketone body production
OHB/AcAc
Cont (15) CRF (15)
J3OHB
Cont (15)
+ AcAc
CRF (15)
Endogenous 0.067 0.003 0.067 0.002 39.7 1.3 41.5 1.6
Oleate 0.549 0.029 0.525 0.033 84.4 2.5 89.6 4.8
Octanoate 0.479 0.029 0.620 0.044a 97.8 2.9 114 2.2a
Isolated hepatocytes from chronic renal failure rats (CRF) and sham-
operated controls (Cont) were incubated for 20 minutes. The number of
incubations in each condition is given in parentheses. Substrate concen-
trations were 2 m. The sum of /3-hydroxybutyrate (I3OHB) and aceto-
acetate (AcAc) production is expressed as jsmol/g dry mass, mean SE.
a Significant differences between the 2 groups.
Materials
Amino acids and lactate were purchased from Sigma Chemical
Co. (Lyon, France). Pyruvate, collagenase A and enzymes were
purchased from Boehringer (Meylan, France). Fructose, oleate,
octanoate, dihydroxyacetone and digitonin were obtained from
Merck (Lyon, France) and rhodorsil silicone oil from Rhône-
Poulenc (Lyon, France). Substrates were of the highest grade of
purification available.
Statistics
Results are given as mean SE. For gluconeogenesis, ureagen-
esis and ketogenesis, differences between groups in each incuba-
tion condition were tested by the Student's t-test. Hepatocyte
respiration and adenine nucleotide concentrations were analyzed
by two-factor repeated-measure ANOVA to compare data from
uremic and control animals as well as to study incubation condi-
tion-related variations. When significant substrate-related differ-
ences were demonstrated by repeated-measure ANOVA, each
parameter variation was studied by one-factor ANOVA. Differ-
ences were considered as significant at the level of P < 0.05.
Results
Gluconeogenesis and ureagenesis
Table 1 shows the endogenous and substrate-induced rates of
gluconeogenesis and ureagenesis. The endogenous rates of both
pathways were unaffected by CRF. Hepatocytes from CRF rats,
when compared with controls, exhibited a significant decrease in
glucose production whatever the tested substrate (P < 0.05). This
decrease in gluconeogenesis ranged from 25% with alanine to
45% with glycerol. Ureagenesis from alanine, glutamine, ammo-
nia and ammonia plus ornithine was also significantly reduced by
uremia (P < 0.05). The reduction of urea synthesis was of the
same order of magnitude as the decrease of gluconeogenesis. It
should be noted that the decrease in urea production when
ornithine was added to ammonia was smaller than with ammonia
alone (17% vs. 41%). Indeed, ornithine addition stimulated
ureagenesis from ammonia by 60% in controls and 136% in CRF
rats.
Ketone body production
Table 2 shows total ketone body production values. Endoge-
nous ketogenesis (sum of /3-hydroxybutyrate and acetoacetate)
was similar in the two groups. As expected, fatty acid addition
1524 Cano et al: Liver cell metabolism during uremia
Table 3. Oxygen uptake and cytosolic and mitochondrial ATPIADP
ratios
02 uptake
ATP/ADP
Cytosol Mitochondria
Controls
Esidogenous
Oleate
12.5 0.8
16.5 0.3a
14.87 0.85
15.13 0.78
1.30 0.06
1.68 0.07e
O + ammonia 20 Ole 16.70 1.34 1.57 O.06
O + L + P 28.1 lie 20.74 l.17e 1.61 O.O9
O + L + P + A 27.3 l.2 19.20 0.86a 1.70 0.02a
CRF
Endogenous
Oleate
13.2 0.38
20.1 1.3e
13.57 1.29
14.08 2.02
1.12 0.04
1.26 0.10
0 + ammonia 21.5 1.2 20.18 1.34 1.32 0.07a
0 + L + P 32.1 1.9 18.05 1.92 1.44 0.07
O + L + P + A 29.5 1.9a 21.32 1.48e 1.59 0.lla
Isolated hepatocytes from chronic renal failure rats (CRF, N = 9) and
sham-operated controls (N 8) were incubated for 20 minutes with oleate
(0), 2 ms, 0 plus ammonia (A), 5 mrvt, 0 plus lactate (L) plus pyruvate
(P), 20-2 ms, and 0 plus L plus P plus A. Oxygen uptake is expressed as
mol/g dry mass/mm, mean SE. Comparisons between CRF and control
groups and according to the incubation conditions were studied by using
a 2-factor repeated-measure ANOVA. For the 02 uptake and cytosolic
ATP/ADP ratio, we found a significant difference depending on the
incubation conditions, but not between the two groups. For mitochondrial
ATPIADP ratio, we found significant differences both between groups and
incubation conditions.
Significant differences between endogenous and substrate-related data.
increased ketogenesis in both groups and this effect was signifi-
cantly more pronounced with octanoate than in presence of
oleate. In addition, ketogenesis was slightly but significantly
higher in CRF rats than in controls (P < 0.05) when octanoate
was added. These effects on total ketone body production were
accompanied by changes in the mitochondrial redox potential as
estimated by the j3-hydroxybutyrate/acetoacetate ratio [36]: this
ratio was identical in the 2 groups at basal state and increased in
both groups after fatty acid addition. Furthermore, the j3-hydroxy-
butyrate/acetoacetate ratio was significantly higher in CRF rats as
compared with controls in presence of octanoate (P < 0.05).
Cellular energy metabolism
Energy metabolism was studied under several conditions from
basal state (that is, the lowest respiratory rates) to the maximal
respiratory rates (stimulation of both ureagenesis and gluconeo-
genesis in presence of oleate).
Table 3 shows the 02 uptake results. In control cells, as usually
reported, oleate addition induced a significant increase in 02
uptake. This respiratory rate was further increased when ammo-
nia, lactate plus pyruvate, or lactate plus pyruvate and ammonia
were added to oleate. These modifications in 02 uptake related to
the incubation conditions were significant. CRF rat hepatocytes
exhibited similar results. It should be stressed that the highest
respiratory rate was obtained with lactate plus pyruvate and oleate
and that ammonia addition did not lead to further increase. Thus,
in these conditions, the increase in 02 uptake either related to
maximal gluconeogenesis or ureagenesis was not cumulative. The
comparison of 02 consumption in the two groups showed that in
every condition uremic hepatocyte respiration tended to be higher
than in controls, although the difference was not significant.
Simultaneously to changes in 02 consumption, cytosolic and
mitochondrial ATP/ADP ratios were affected by incubation con-
ditions (Table 3). In control cells, the cytosolic ATP/ADP ratio
was significantly higher when maximal respiratory rate occurred,
that is, when gluconeogenesis was activated (addition of oleate
plus lactate plus pyruvate and oleate plus lactate plus pyruvate
plus ammonia). Concomitantly, the mitochondrial ATP/ADP
ratio was significantly increased with every tested substrate com-
pared with basal conditions. In hepatocytes from CRF rats, the
cytosolic ATP/ADP ratio was also increased by substrate addition.
This increment was significant only when ureagenesis was stimu-
lated (addition of oleate plus ammonia and oleate plus lactate
plus pyruvate plus ammonia). Mitochondrial ATP/ADP ratio
elevation, observed with every substrate, was significant when
gluconeogenesis and/or ureagenesis were stimulated.
The comparison between the two groups did not show any
difference in cytosolic ATP/ADP ratios. On the other hand, the
mitochondrial ATP/ADP ratio was lower in every condition in
CRF rat cells with a significant difference at basal state and with
oleate and oleate plus ammonia as substrates (P < 0.05).
The changes in cytosolic and mitochondrial ATP/ADP ratios
described above could be due to variations of either ATP or ADP
or both. Moreover, the AMP and total nucleotide content also
could be affected by incubates and uremia. Cytosolic and mito-
chondrial ATP, ADP and AMP concentrations are given in Table
4. The sum ATP plus ADP plus AMP was identical in control and
uremic rat hepatocytes both in cytosol and in mitochondria.
Among cytosolic nucleotides, only ADP was significantly affected
by the incubation conditions. In controls, ADP was lower when
gluconeogenesis was enhanced whereas in the CRF group, ADP
was reduced in the conditions stimulating ureagenesis. The com-
parison of the two groups revealed a significant increase in ATP
and in the sum ATP plus ADP in uremic hepatocytes (P < 0.05).
In the mitochondrial space, substrate additions significantly
affected ATP, ADP and AMP. ATP was reduced by the addition
of oleate and oleate plus ammonia in both control and CRF cells,
these variations reaching significance in controls only. ADP
concentrations were significantly decreased by all substrates in the
two groups. AMP concentrations were significantly increased,
both in control and CRF rat hepatocytes, in the presence of
oleate. The comparison of the two groups showed a significant
ADP increase in uremic rat mitochondrial space (P < 0.05).
Several conclusions can be drawn from these data on cell energy
metabolism: (1) oxygen uptake was significantly enhanced by
substrate addition both in control and CRF cells; (2) the increase
of cell respiration was associated with an increase in ATP/ADP
ratios in cytosol and mitochondria mainly due to an ADP de-
crease; (3) the main changes in cytosolic ADP concentration and
ATP/ADP ratio were associated with the stimulation of glucone-
ogenesis in control hepatocytes and ureagenesis in uremia;
(4) CRF was characterized by an increase in cytosolic ATP and
mitochondrial ADP, a decrease in mitochondrial ATP/ADP ratio
and a slight but not significant increase in 02 uptake.
Discussion
Liver dysfunction seems to play a key role in the pathogenesis
of undernutrition in end-stage renal insufficient patients. The aim
of this work was to investigate the effect of CRF on the interme-
diary metabolism of the isolated hepatocyte.
In the present study, CRF animals presented moderate renal
insufficiency as previously reported in similar models [37]. Al-
though several studies of CRF in rats show a significant loss of
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Table 4. Cytosolic and mitochondrial adenine nucleotides
ATP ADP AMP ATP+ADP ATP+ADP +AMP
Cytosol
Controls (N = 8)
Endogenous 9.92 0.39 0.68 0.04 2.03 0.45 10.60 0.41 12.63 0.66
Oleate 9.12 0.29 0.62 0.05 1.59 0.38 9.74 0.32 11.33 0.58
O+L+P 10.19 0.34 0.51 0.04a 1.60 0.34 10.70 0.36 12.29 0.36
O+A 9.79 0.24 0.61 0.04 1.94 0.29 10.40 0.23 12.34 0.34
O+L+P+A 10.04 0.25 0.53 0.03a 1.55 0.34 10.58 0.27 12.13 0.32
CRF (N = 9)
Endogenous 10.41 0.25 0.80 0.07 1.38 0.20 11.21 0.29 12.60 0.29
Oleate 10.78 0.81 0.97 0.20 1.23 0.12 11.75 0.72 12.98 0.81
O+L+P 10.84 0.33 0.65 0.07 0.99 0.05 11.49 0.34 12.48 0.34
O+A 10.36 0.31 0.53 0.04 1.33 0.07 10.89 0.32 12.22 0.31
O+L+P+A 10.60 0.30 0.52 0.04 1.01 0.03 11.11 0.33 12.12 0.36
Mitochondria
Controls (N = 8)
Endogenous 2.83 0.16 2.19 0.11 1.21 0.15 5.03 0.25 6.23 0.43
Oleate 2.34 0.13a 1.39 0.06 1.65 0.17 3.73 o.18 5.38 0.23
O+A 2.41 QQ9 1.54 Q•Ø4 1.60 0.17 3.96 0.12 5.56 0.10
O+L+P 2.64 0.12 1.66 0.06 0.89 0.16 4.30 0.13 5.19 0.12
O+L+P+A 2.74 0.08 1.61 0.Osa 0.97 0.16 4.35 0.12 5.32 0.11
CRF (N = 9)
Endogenous 2.55 0.08 2.29 0.10 1.08 0.15 4.84 0.16 5.92 0.11
Oleate 2.17 0.18 1.75 o.la 1.76 o.lOa 3.92 0.24a 5.68 0.30
O+A 2.27 0.12 1.73 0.06a 1.55 0.13 3.99 0.17 5.55 0.12
O+L+P 2.48 0.12 1.74 0.06a 0.83 0.13 4.22 0.14a 5.05 0.13
O+L+P+A 2.42 0.07 1.55 0.07a 0.73 0.10 3.98 0.08a 4.71 o.la
Incubation conditions and abbreviations are as indicated in Table 3. Comparisons between CRF and control groups and according to the incubation
conditions were studied by using a two-factor repeated-measure ANOVA. Significant differences between control and CRF groups were found for
cytosolic ATP, mitochondrial ADP and the sum of cytosolic ATP and ADP, whereas incubate-related differences were found to be significant for
cytosolic AMP, cytosolic ADP and mitochondrial ATP, ADP, AMP, ATP plus ADP, and ATP plus ADP plus AMP.
a Significant differences between endogenous and substrate-related data.
weight [23, 37], this was not the case in our group. This can be
explained by two factors. First, we used adult rats weighing 300 g.
As reported in a chronic acidosis model [38, 39], the body mass of
animals of this size seems to be only slightly affected by CRF. In
the present model, food intakes were similar in CRF rats and
controls during the week before hepatocyte isolation. Secondly,
the experimental procedure used (partial left renal artery ligation
2 weeks before nephrectomy) was chosen to decrease the severity
of insult. This point is of great importance since the nutritional
status and the severity of stress are well known to alter hepatocyte
metabolism [20, 23, 40].
The decrease of gluconeogenesis in CRF animals reported here
was significant and ranged from 25% to 45% according to the
tested substrate. These results were in accordance with a previous
study with alanine, glutamine and serine [23]. In the present work,
several steps of gluconeogenic pathway were studied by using
different gluconeogenic precursors: pyruvate-phosphoenolpyru-
vate cycle with lactate plus pyruvate [41], amino acid transport
across plasma membrane by alanine [261, glutaminase activity by
glutamine [42, 43], cytosolic redox potential by glycerol [44],
pyruvate kinase activity by dihydroxyacetone [451, and fructose 1-6
diphosphate cycle by fructose [46]. These results suggested a
general effect of CRF on gluconeogenesis since all pathways were
affected.
Ureagenesis was significantly diminished with all substrates
used in the same proportion as gluconeogenesis. In particular with
alanine and glutamine, the effect of uremia was the same in the
two pathways for each substrate. These findings are in accordance
with classic reports on gluconeogenesis and ureagenesis interre-
lationships [27, 28]. Studying a model of isolated hepatocytes
similar to ours, Klim et al [23] reported an increased ureagenesis
together with a decreased gluconeogenesis from alanine and
glutamine. The discrepancy between the two studies may be
explained by two differences in the experimental design. First, the
methods for obtaining renal insufficiency (partial nephrectomy
instead of arterial ligation) and the delay between surgery and
hepatocyte isolation were different and may have induced a
different level of stress. Indeed, the effect of the procedure used
by Klim et al [23] resulted in significant changes in nutritional
status leading these authors to study a pair-fed group (reducing by
the oral intake of controls). Secondly, these authors measured
total ammonia accumulation (ammonia plus urea) and not only
urea production. This could be of importance because, as re-
ported here, ureagenesis from ammonia was impaired during
CRF. Therefore, the act of considering the accumulation of
ammonia and urea together may induce an overestimation of
ureagenesis flux. Moreover, as pointed out by Meijer et al [27, 281
in in vitro conditions, cellular concentrations of urea cycle inter-
mediates can be flux-limiting. Indeed, in the present study, the
addition of ornithine increased ureagenesis from ammonia and
this effect was more pronounced in uremic rat hepatocytes. In
addition, it has been shown that the availability of carbon precur-
sor for aspartate formation limits urea synthesis in hepatocytes
incubated with ammonia and ornithine [47]. This may account for
the fact that synthesis of urea under these conditions was lower
than that observed in the presence of glutamine (Table 1). Thus,
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decreased aspartate formation is a possible cause of the reduction
of urea synthesis observed in hepatocytes from CRF rats in the
presence of ammonia and ornithine.
Taken together, the present data on gluconeogenesis and
ureagenesis suggested a general effect of CRF on isolated hepa-
tocyte metabolism rather than specific alterations of these path-
ways. Following this hypothesis, one could expect that other
pathways would be affected in a similar manner. Although we did
not directly study fatty acid consumption, the measurement of
ketone body production and 02 uptake in the presence of fatty
acids provided an insight into their metabolism. CRF was associ-
ated with either no change or a slight increase in ketone body
production and fatty acid-induced respiratory rate. Thus, 13-oxy-
dation and ketogenesis were not altered by CRF. It is of interest
to note that octanoate addition resulted in a slight but significantly
higher ketone body production together with a higher -hydro-
butyrate/acetoacetate ratio in hepatocytes from CRF rats com-
pared with controls. As the major difference between oleate and
octanoate metabolism in liver cell is represented by the location of
their activation [48, 491, these data suggest an increased intra-
mitochondrial activation of medium-chain fatty acid in CRF.
Since oxidative phosphorylation accounts for most ATP pro-
duction, 02 uptake can be considered as a reliable reflection of
ATP turnover. When compared with controls, CRF rat hepato-
cytes exhibited a slight increase in 02 consumption which never
reached significance. Thus, ATP turnover in CRF hepatocyte was
probably as high as in control cells. This contrasts with the 30%
decrease in both glucose and urea production when ureagenesis
and/or gluconeogenesis were maximally stimulated. This discrep-
ancy suggests that other energy consuming processes may be
involved in CRF rat hepatocyte. The existence of such a waste of
energy may also be suggested by the fact that the mitochondrial
ATP/ADP ratio was significantly lower in CRF rat hepatocyte
while the total adenine nucleotide content was not modified. The
diminution of the mitochondrial ATP/ADP ratio in CRF rat
hepatocyte due to ADP increase was not accompanied by a
decrease in the cytosolic ATP/ADP ratio. This can be explained by
the adenylate kinase activity which tends to buffer the cytosolic
ATP/ADP ratio [50].
At a steady state of ATP turnover (stable 02 consumption), a
decrease in the mitochondrial ATP/ADP ratio can be essentially
explained either by an increased ATP demand or by a decrease in
oxydative phosphorylation efficiency. Our data do not make it
possible to definitely rule out either of these hypotheses. How-
ever, in isolated mitochondria from control and CRF rat hepato-
cytes, we were not able to find any change in state 4 and state 3
oxygen uptakes, uncoupled maximal respiratory rate or in state 4
ATP/ADP and ATP/0 ratios (data not shown). These data in
isolated mitochondria strongly argue against a diminished mito-
chondrial efficiency.
Thus, these data on hepatocyte intermediary metabolism in
CRF rats essentially showed (1) an alteration of stimulated
gluconeogenesis and ureagenesis, and (2) a decrease in mitochon-
drial ATP/ADP ratio associated with normal °2 uptake. The role
of the insulin/glucagon ratio in the alteration of gluconeogenesis
has been evoked [231. The decrease in ureagenesis is consistent
with the diminution of carbamoyl phosphate synthetase and
ornithine transcarbamoylase activities reported in a similar rat
model [17]. Among the metabolic disturbances linked to CRF,
acidosis may explain the decrease of both gluconeogenesis and
ureagenesis [51—54]. In this experimental model, extracellular pH
(incubation medium) was identical in both groups, making it
possible to exclude a direct effect of this factor. However, a
chronic effect of acidosis on enzyme activities can be evoked. As
a matter of fact, in isolated hepatocytes from chronically acidotic
rats, a reduction of gluconeogenesis and ureagenesis from glu-
tamine has been reported [55]. One could also speculate on the
role of acidosis on cell respiration and energy status. However,
although the pH of the incubation medium can influence 02
consumption and ATP production by isolated hepatocytes (un-
published personal data), the effect of chronic acidosis on cell
respiration and energy status is poorly known.
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